0001171000-15-000049.txt : 20150702
0001171000-15-000049.hdr.sgml : 20150702
20150702141712
ACCESSION NUMBER: 0001171000-15-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Geraldine T
CENTRAL INDEX KEY: 0001632385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15968778
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-07-01
0001618561
Nexvet Biopharma plc
NVET
0001632385
Farrell Geraldine T
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE, MOUNT MERRION
BLACKROCK, CO. DUBLIN
L2
IRELAND
0
1
0
0
VP Operations, General Counsel
Ordinary Shares
2015-07-01
4
M
0
2867
.125
A
10758
I
By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>
Ordinary Shares
4300
D
Ordinary Shares
132
I
By Nexvet EBT Limited
Options to purchase shares
.125
2015-07-01
4
M
0
2867
0
D
2015-07-01
2019-07-01
Ordinary Shares
2867
10033
I
By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C
The reporting person and her spouse share voting and dispositive power with respect to these reported securities.
The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule hereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.
2,867 options vested and became exercisable on 7/1/15; a further 2,867 options shall vest and become exercisable on 7/1/16, and 2,866 will vest on 7/1/17. The remaining 4,300 options will vest and be exercisable upon successful completion of an efficacy trial for any Issuer product, as determined by Issuer's board of directors; such completion must occur on or before 7/1/19.
/s/ Geraldine T. Farrell
2015-07-02